Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Targeting the cyp1b1 enzyme for radioactivity 18 f-labeled probe precursor

A radioactive and labeling technology, applied in the field of PET imaging and tumor diagnosis, which can solve the problems of low diagnostic specificity and difficult diagnosis.

Active Publication Date: 2022-01-11
SHANGHAI JIAOTONG UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Finish 18 After F labeling, through PET imaging of intracellular CYP1B1 enzyme, its expression site and level are displayed in vivo, providing a new method for early diagnosis of tumors, and solving the problems of difficult diagnosis and low diagnostic specificity in current tumor treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeting the cyp1b1 enzyme for radioactivity  <sup>18</sup> f-labeled probe precursor
  • Targeting the cyp1b1 enzyme for radioactivity  <sup>18</sup> f-labeled probe precursor
  • Targeting the cyp1b1 enzyme for radioactivity  <sup>18</sup> f-labeled probe precursor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] The present embodiment relates to a kind of radioactive compound derived from 6,7,10-trimethoxy-3'-fluoro-α-naphthalene flavonol with structural formula I 18 Preparation method of F-labeled probe precursor I-3, such as figure 1 shown, including the following steps:

[0029] Step 1: Dissolve 2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)ethanol (2mmol) in 6mL of dichloromethane, add dropwise in 4mL dichloromethane under ice-cooling Di-tert-butyl dicarbonyl ester of methyl chloride (2.3 mmol). After the dropwise addition, the ice bath was removed, and the reaction solution was stirred overnight at room temperature. After the reaction, the reaction solution was diluted with 10 mL of dichloromethane, and the organic phase was washed successively with an equal volume of water, saturated sodium bicarbonate solution and saturated sodium chloride solution. After drying the organic phase with anhydrous sodium sulfate, it was concentrated under reduced pressure to obtain a colorless oi...

Embodiment 2

[0035] The present embodiment relates to a kind of radioactive compound derived from 6,7,10-trimethoxy-3'-fluoro-α-naphthalene flavonol with structural formula I 18 Preparation method of F-labeled probe precursor I-1, such as figure 1 shown, including the following steps:

[0036] Step 1: Same as Step 5 of Example 1, replace V-3 with V-1 (see published paper J.Med.Chem., 2018, 61, 10901-10909 for the synthesis method), Rf=27.525min, and obtain an orange-yellow solid I-1 (n=1). Yield, 52.4%. 1 H NMR (600MHz, DMSO-d 6 ):δ9.80(s,1H),8.27-8.35(m,2H),7.67-7.70(m,1H),7.58(d,J=6.0Hz,2H),7.41-7.44(m,3H), 7.30-7.32(m,3H),4.41(s,2H),4.28(s,2H),4.06(s,3H),3.94(s,3H),3.84(s,3H),3.75(s,2H) ,3.64(s,2H),3.55-3.57(m,2H),3.42-3.47(m,4H),3.30(m,2H),3.11(m,4H),3.00-3.03(m,2H),2.79 (m,2H),2.61-2.68(m,4H). 13 C NMR (150MHz, DMSO-d 6 ), 130.87,125.00,123.00,121.57,121.44,117.92(d,J=17.8Hz),117.58,117.47,115.80, 115.40(d,J=21.3Hz),113.94,110.59,98.03,71.30,668.89.85,5, 57.83, 56.87, 56.61,...

Embodiment 3

[0038] The present embodiment relates to a kind of radioactive compound derived from 6,7,10-trimethoxy-3'-fluoro-α-naphthalene flavonol with structural formula I 18 Preparation method of F-labeled probe precursor I-2, such as figure 1 shown, including the following steps:

[0039] step one:

[0040] Same as Step 5 of Example 1, replace V-3 with V-2 (see the published paper J.Med.Chem., 2018, 61, 10901-10909 for the synthesis method), Rf=27.865min, and obtain orange-yellow solid I-2 (n=2), yield: 72%. 1 H NMR (600MHz, DMSO-d 6 ):δ9.77(s,1H),8.28-8.37(m,2H),7.67-7.71(m,1H),7.57(d, J=6.6Hz,2H),7.43-7.49(m,3H), 7.31-7.33(m,3H),4.40(m,2H),4.29(s,2H),4.07(s,3H),3.95(s,3H),3.85(s,3H),3.72(m,2H) ,3.62(m,2H),3.53-3.54(m,6H),3.42-3.48(m,4H),3.30(m,2H),3.12(m,4H),3.01-3.03(m,2H),2.79 (m,2H),2.61-2.68(m,4H). 13 C NMR (150MHz, DMSO-d 6 ), 130.87, 125.03, 122.96, 121.58, 121.47, 117.89 (d, J=17.9Hz), 117.62, 115.44 (d, J=21.0Hz), 113.98, 110.63, 98.08, 71.29, 70.08, 70.06, 70.9870,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a radioactive drug targeting CYP1B1 enzyme 18 F-labeled probe precursors; the probe precursors include affinity ligands that can be combined with CYP1B1 enzymes, and can be used for 18 The chelating group of F rapid label and the linking chain that is used to connect part and chelating group; The linking chain comprises multiple ethylene glycol fragments; The affinity part is α-naphthoflavone derivative, available At 18 The chelating group of F rapid labeling is 1,4,7-triazacyclononane-1,4-diacetic acid molecule. The present invention is a kind of CYP1B1 enzyme that can be combined with tumor-specific expression, and can be used for 18 F-labeled molecular probe precursor, after radiolabeling, can show the level of CYP1B1 enzyme in the tumor in PET imaging to visualize the tumor. The invention will effectively promote the application of molecular imaging technology in tumor diagnosis.

Description

technical field [0001] The invention relates to the fields of PET imaging and tumor diagnosis, and relates to a radionuclide targeting CYP1B1 enzyme 18 F-labeled probe precursors; specifically one composed of ethylene glycol chains will be available for 18 The diagnostic reagent complex composed of F-labeled chelating groups and ligands that can specifically bind to cytochrome P450 1B1 enzymes is radioactive 18 F labeling allows visualization of tumors in PET imaging by showing levels of cytochrome P450 1B1 enzyme for tumor diagnosis. Background technique [0002] Compared with traditional medical imaging, molecular imaging shows a better application prospect in the early diagnosis of tumors. Through the high-affinity enrichment effect of molecular probes on specific targets of tumor tissue, tumor imaging can be performed in the early stage of tumor occurrence or even before symptoms appear, and the effect of early diagnosis can be achieved. With the development of tumor ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D405/12A61K51/04A61K101/02
CPCC07D405/12A61K51/044C07B2200/05
Inventor 孟青青陈冬梅范琪琪李绍顺董金云崔家华王增涛
Owner SHANGHAI JIAOTONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products